1. A Phase 1/2 Trial of Carfilzomib + High Dose Melphalan Conditioning for Auto-HCT Followed by Carfilzomib Maintenance for Patients with Relapsed Multiple Myeloma 
Luciano J. Costa, Heather Landau, Saurabh Chhabra, Parameswaran Hari, Racquel Innis-Shelton, Ayman Saad, Donna Salzman, Mehdi Hamadani, Roni Tamari, Lisa Williams, Evelyn Orlando, Pamela Dixon, Sergio A. Giralt 
Biology of Blood and Marrow Transplantation 
Volume 23, Issue 3, Pages S81-S82 (March 2017)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1 Phase 1 treatment scheme.
Biology of Blood and Marrow Transplantation  , S81-S82DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2
MM disease assessment before and 100 days after K-Mel auto-HCT.
Biology of Blood and Marrow Transplantation  , S81-S82DOI: ( /j.bbmt )
Copyright © Terms and Conditions

4. Figure 3
PFS of relapsed MM patients undergoing K maintenance after K-Mel auto-HCT.
Biology of Blood and Marrow Transplantation  , S81-S82DOI: ( /j.bbmt )
Copyright © Terms and Conditions